Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-25 @ 2:39 AM
NCT ID:
NCT02039934
Eligibility Criteria:
Inclusion criteria:
* Men and women
* Age: 30 - 65 years
* Typ-2-Diabetes (BMI \> 25 kg/m²)
* Increased risk for diabetes (BMI \>25 kg/m²)
Exclusion criteria:
* Acute Infection within the last 2 weeks prior to the intervention
* Autoimmune diseases and immune suppressive diseases (Leukocytes \< 5000/μl)
* Intake of immunomodulating drugs (Glucocorticoids, Antihistamine, ASS)
* Pregnancy, Breastfeeding, Menstruation
* Kidney insufficiency (Creatinine \> 1,5 mg/dl)
* Cardiovascular diseases
* Anemia (Hb \< 12g/l), disorders of wound healing or blood clotting
* Participation in another study within the last 2 months before the investigation
* Metallic or magnetic items on or in the body
* Claustrophobia
* Thyroid dysfunction
* Intake of glitazones or insulin therapy
* Smoking (Non-smoking since \> 1 year), alcohol consumption (Men \> 30 g/d, Women \> 20g/d) or illegal drugs
* Psychiatric disorders
* Risk for/or manifest AIDS (HIV) or Hepatitis B or C
* Night shift working
* Hypersensitivity to local anesthetics
* Cancer disease
* Lung diseases
* Systematic endurance training (\>1x per week \> 60min.)
* Maximal oxygen consumption (VO2 max) \<20ml/min/kg
* Orthopedic disorders
* Musculoskeletal diseases
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
65 Years
Study:
NCT02039934
Study Brief:
Protocol Section:
NCT02039934